| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |